AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sign up Log in

Indigenous Bloom Hemp Corp. Capital/Financing Update 2021

Sep 8, 2021

47231_rns_2021-09-08_1ae792ac-3626-4828-bc64-badb50a661ee.pdf

Capital/Financing Update

Open in viewer

Opens in your device viewer

==> picture [108 x 58] intentionally omitted <==

Veritas Pharma Announces Conversion of Note

VANCOUVER, British Columbia, September 8, 2021 -- Veritas Pharma Inc. (CSE: VRT; OTC: VRTHF; and Frankfurt: 2VP) (“the “ Company ”) announces that further to its news release of October 29, 2020, the noninterest bearing convertible note in the principal amount of $85,000 which it issued in settlement of debt has been converted into 566,667 common shares of the Company at a deemed price of $0.15 per share.

On behalf of the Board of Directors

Peter McFadden Chief Financial Officer

Further information about the Company is available on our website at www.veritaspharmainc.com or under our profile on SEDAR at www.sedar.com, and on the CSE website at www.thecse.com.

Investor and Public Relations Contact

Veritas Pharma Inc. Telephone: +1.416.918.6785 Email: [email protected] Website: www.veritaspharmainc.com

The CSE has not reviewed, nor approved or disapproved the content of this press release. 142665\4821-6849-0490